pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-127 |
Genomic Coordinates | chr14: 100882979 - 100883075 |
Description | Homo sapiens miR-127 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-127-5p | ||||||
Sequence | 23| CUGAAGCUCAGAGGGCUCUGAU |44 | ||||||
Evidence | Experimental | ||||||
Experiments | Cloned | DRVs in miRNA |
|
||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | COPA | ||||||||||||||||||||
Synonyms | AILJK, HEP-COP | ||||||||||||||||||||
Description | coatomer protein complex subunit alpha | ||||||||||||||||||||
Transcript | NM_001098398 | ||||||||||||||||||||
Other Transcripts | NM_004371 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on COPA | |||||||||||||||||||||
3'UTR of COPA (miRNA target sites are highlighted) |
>COPA|NM_001098398|3'UTR 1 GGCCCCCTTTGTGTGCATGGGTCAGTCACCATATGTTCCCCCCAGAGAATGTGTCTATATCCTCCTTCTAACAGCACCTT 81 CCCCCTGCAGCTACTCTTCAGATCTGGCTCTCTGTACCCTAAAACCTAGTATCTTTTTCTCTTCTATGGAAAATCCGAAG 161 GTCTAAACTTGACTTTTTTGAGGTCTTCTCAACTTGACTACAGTTGTGCTCATAATTGTCCTTGCCTTTCCAGCTTAATT 241 ATTTTAAGGAACAAATGAAAACTCTGGGCTGGGTGGAGTGGCTCATACCTGTAATCCCAGCACTTTGGGAGGCTACGGTG 321 GGCAGATCATCTGAGGCCAGGAGTTCGAGACCTGCCTGGCCAACATGGCAACACCCCGTCTCTAATAAAAATATAAAAAT 401 TAGCCTGGCATGGTAGCATGCGCCTATAGTCCCAGCTGCTCAGGAGGCTGAGGCATGAGAATCGCTTGAACCTAGGAGGT 481 GGAGGTTGCATTCAACTGAGATCATACCACTTCATTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAAAAAAAAA 561 AAGGAAAACTCTGTGATGGACATTTGTTTAGTAAATCCCTTCAGTATTTATCCCTCCTTTCCCCACAGCAGCTTTCTTTC 641 CTGTCAACTAGAAAGGAGCAGGATGTAATAAATACATTTTGGTGTGACTAGGCCACACCAACTCTTAATCATCTCCCATT 721 TTCCTTAGACATTTAAATTTCAAGGCAGGTACCCTCTGTGTACTCAGAAATTTGAAGAAGTTATTTGGTTTTCCAAAATG 801 CACACTGCGGGTTATTGATTTGTTCTTTACAACTATTGTTCTCATATTTCTCACACTAAATAAATCTCTATGAGAGCTTC 881 TTGACTTGGCCATTTATTTCTTGGACACTCTCATGTTCTTGTTCACCCATGCAGGCACCCCACCAAAGTACATATCTTCC 961 TTCCAGTAATAATTTTTAATTACAAAATAAACATCCACTATTGGAAAAAAAAAAAAAAAGCTAGCCGGGCATGGTGGTGG 1041 GTGCCTGTAATCCCAGCTACTCTGGAGGCTGAGGCAGAGGATTGCTTGAACCCGGGAGGCGGAGGTTGCAGTAAGCTGAG 1121 ATCGCGCCACCGCACTCCAGCCTGGGCGACAGAGTGAGACTCCATCTCAAAAAAAAAGAAAGAAAAAAAGAAGCACATGT 1201 TTTTCATAGGGTATATATGAGGACCTAAACTGCTGTGAAAATGATAGAAAGCAAGTAGCTCCCTTATTCTGTTTTTGATT 1281 GCAGCCTTTTATCTTTTGCTAATTATAGCAATATTTATTGAGCACCTGCCATGTGACTGTCACTGTTCTAGATATTTTAC 1361 ATGTAATATACAGATAAAAGAATAGTACTTTATATATATTACAATGATACAATGATTACATTAACAATACAATATTTTGC 1441 TTGTCATATGCTAAGAATAATTGGGTAGAGTGACATTACTGTGCCTTCGATTAAAATAAGTACTTTTTTGCGTGTTAAAT 1521 TCATGTTTTCAATAAATAATAAATGCATATAGTTGAAAAATCAGTAAATA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
113 hsa-miR-127-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT380928 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT439324 | USP34 | ubiquitin specific peptidase 34 | 1 | 1 | ||||||||
MIRT439333 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT439379 | TTC37 | tetratricopeptide repeat domain 37 | 1 | 1 | ||||||||
MIRT439445 | TMEM116 | transmembrane protein 116 | 1 | 1 | ||||||||
MIRT439498 | SYNJ2 | synaptojanin 2 | 1 | 1 | ||||||||
MIRT439525 | STBD1 | starch binding domain 1 | 1 | 1 | ||||||||
MIRT439562 | SORL1 | sortilin related receptor 1 | 1 | 1 | ||||||||
MIRT439660 | SF3B1 | splicing factor 3b subunit 1 | 1 | 1 | ||||||||
MIRT439749 | ROGDI | rogdi homolog | 1 | 1 | ||||||||
MIRT439836 | RAB3B | RAB3B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT439923 | PPL | periplakin | 1 | 1 | ||||||||
MIRT439963 | PKD1 | polycystin 1, transient receptor potential channel interacting | 1 | 1 | ||||||||
MIRT439985 | PHKG2 | phosphorylase kinase catalytic subunit gamma 2 | 1 | 1 | ||||||||
MIRT440029 | PCLO | piccolo presynaptic cytomatrix protein | 1 | 1 | ||||||||
MIRT440179 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440183 | MTRNR2L4 | MT-RNR2-like 4 | 1 | 1 | ||||||||
MIRT440184 | MTRNR2L6 | MT-RNR2-like 6 | 1 | 1 | ||||||||
MIRT440194 | MTRNR2L1 | MT-RNR2-like 1 | 1 | 1 | ||||||||
MIRT440269 | MBP | myelin basic protein | 1 | 1 | ||||||||
MIRT440323 | LIN7C | lin-7 homolog C, crumbs cell polarity complex component | 1 | 1 | ||||||||
MIRT440331 | LGALS8 | galectin 8 | 1 | 1 | ||||||||
MIRT440355 | KLHL29 | kelch like family member 29 | 1 | 1 | ||||||||
MIRT440397 | KDM6B | lysine demethylase 6B | 1 | 1 | ||||||||
MIRT440411 | KAT2B | lysine acetyltransferase 2B | 1 | 1 | ||||||||
MIRT440424 | ITCH | itchy E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT440651 | FBXO7 | F-box protein 7 | 1 | 1 | ||||||||
MIRT440773 | DST | dystonin | 1 | 1 | ||||||||
MIRT440824 | DGKD | diacylglycerol kinase delta | 1 | 1 | ||||||||
MIRT440914 | COPA | coatomer protein complex subunit alpha | 1 | 1 | ||||||||
MIRT441118 | BBS4 | Bardet-Biedl syndrome 4 | 1 | 1 | ||||||||
MIRT441153 | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 1 | 1 | ||||||||
MIRT441193 | ARID1A | AT-rich interaction domain 1A | 1 | 1 | ||||||||
MIRT441260 | ADM | adrenomedullin | 1 | 1 | ||||||||
MIRT441282 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT441306 | ABHD2 | abhydrolase domain containing 2 | 1 | 1 | ||||||||
MIRT441860 | TEX35 | testis expressed 35 | 2 | 2 | ||||||||
MIRT442190 | CCDC132 | VPS50, EARP/GARPII complex subunit | 2 | 2 | ||||||||
MIRT442886 | RHCG | Rh family C glycoprotein | 2 | 2 | ||||||||
MIRT444158 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444506 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444770 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT445830 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445850 | LRRC1 | leucine rich repeat containing 1 | 2 | 2 | ||||||||
MIRT445863 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446161 | C8A | complement C8 alpha chain | 2 | 2 | ||||||||
MIRT447117 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447990 | CDX1 | caudal type homeobox 1 | 2 | 2 | ||||||||
MIRT449032 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 2 | 2 | ||||||||
MIRT449295 | SMIM19 | small integral membrane protein 19 | 2 | 2 | ||||||||
MIRT449541 | PCDH9 | protocadherin 9 | 2 | 2 | ||||||||
MIRT449579 | ZNF510 | zinc finger protein 510 | 2 | 2 | ||||||||
MIRT450062 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450437 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 2 | ||||||||
MIRT450449 | ZDHHC2 | zinc finger DHHC-type containing 2 | 2 | 2 | ||||||||
MIRT450695 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT453654 | RAB6C | RAB6C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT463771 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT468425 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468843 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT475594 | HMGB2 | high mobility group box 2 | 4 | 4 | ||||||||
MIRT478284 | DDX19A | DEAD-box helicase 19A | 2 | 2 | ||||||||
MIRT487594 | NKD2 | naked cuticle homolog 2 | 2 | 4 | ||||||||
MIRT493440 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 6 | ||||||||
MIRT496169 | RPL35A | ribosomal protein L35a | 2 | 4 | ||||||||
MIRT497566 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT497917 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498331 | PRELID2 | PRELI domain containing 2 | 2 | 2 | ||||||||
MIRT498369 | KLHL11 | kelch like family member 11 | 2 | 2 | ||||||||
MIRT498856 | LITAF | lipopolysaccharide induced TNF factor | 2 | 2 | ||||||||
MIRT505640 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT506128 | PLRG1 | pleiotropic regulator 1 | 2 | 4 | ||||||||
MIRT512242 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 4 | ||||||||
MIRT512489 | ARID2 | AT-rich interaction domain 2 | 2 | 2 | ||||||||
MIRT525251 | RNF213 | ring finger protein 213 | 2 | 2 | ||||||||
MIRT530197 | ALX1 | ALX homeobox 1 | 2 | 4 | ||||||||
MIRT530551 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT534048 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT537508 | FAM105A | family with sequence similarity 105 member A | 2 | 2 | ||||||||
MIRT543005 | CRK | CRK proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT543814 | SNX10 | sorting nexin 10 | 2 | 2 | ||||||||
MIRT549303 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT549407 | ADIPOR2 | adiponectin receptor 2 | 2 | 4 | ||||||||
MIRT550547 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT554319 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 2 | ||||||||
MIRT554515 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT559603 | AMOT | angiomotin | 2 | 2 | ||||||||
MIRT564844 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT566125 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 2 | 2 | ||||||||
MIRT567484 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT576521 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT633635 | CASC5 | kinetochore scaffold 1 | 2 | 2 | ||||||||
MIRT639325 | C9orf41 | carnosine N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT643174 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT651214 | ZNF225 | zinc finger protein 225 | 2 | 2 | ||||||||
MIRT653039 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT653042 | STOX2 | storkhead box 2 | 2 | 2 | ||||||||
MIRT658769 | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | 2 | 2 | ||||||||
MIRT666728 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT681223 | DUSP19 | dual specificity phosphatase 19 | 2 | 2 | ||||||||
MIRT685562 | SRD5A3 | steroid 5 alpha-reductase 3 | 2 | 2 | ||||||||
MIRT687434 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT688439 | DNAJC3 | DnaJ heat shock protein family (Hsp40) member C3 | 2 | 2 | ||||||||
MIRT692707 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT700552 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT704955 | CBX2 | chromobox 2 | 2 | 2 | ||||||||
MIRT714524 | ALKBH3 | alkB homolog 3, alpha-ketoglutaratedependent dioxygenase | 2 | 2 | ||||||||
MIRT716225 | DGKI | diacylglycerol kinase iota | 2 | 2 | ||||||||
MIRT717953 | MIA3 | MIA family member 3, ER export factor | 2 | 2 | ||||||||
MIRT719902 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT732044 | BLVRB | biliverdin reductase B | 3 | 1 | ||||||||
MIRT733622 | SNX5 | sorting nexin 5 | 3 | 0 | ||||||||
MIRT737210 | CXCR4 | C-X-C motif chemokine receptor 4 | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|